Weiren Xu
- Molecular Biology top 10%
- Organic Chemistry top 5%
- Oncology top 10%
- Computational Theory and Mathematics top 2%
- Surgery
- Co-authors
- Run‐Ling WangShuqing WangTang Li-daKuo‐Chen ChouFancui MengYing MaXian‐Chao ChengJianwu Wang
- Topics
- Peroxisome Proliferator-Activated Receptors (15 papers)Diabetes Treatment and Management (11 papers)Synthesis and biological activity (10 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weiren Xu
95 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 902
- Organic Chemistry 332
- Oncology 315
- Computational Theory and Mathematics 205
- Surgery 187
Countries citing papers authored by Weiren Xu
This map shows the geographic impact of Weiren Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiren Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiren Xu more than expected).
Fields of papers citing papers by Weiren Xu
This network shows the impact of papers produced by Weiren Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiren Xu. The network helps show where Weiren Xu may publish in the future.
Co-authorship network of co-authors of Weiren Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Weiren Xu. A scholar is included among the top collaborators of Weiren Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiren Xu. Weiren Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 7 | |
| 3 | 5 | |
| 4 | 4 | |
| 5 | 26 | |
| 6 | 20 | |
| 7 | 11 | |
| 8 | Determination of dabigatran in rat plasma by HPLC | 2 |
| 9 | 32 | |
| 10 | 1 | |
| 11 | 98 | |
| 12 | 13 | |
| 13 | 16 | |
| 14 | 35 | |
| 15 | 4 | |
| 16 | 27 | |
| 17 | 51 | |
| 18 | 34 | |
| 19 | 48 | |
| 20 | [Clinical study on effect of shengmai injection on serum concentration and pharmacokinetic parameters of digoxin in patients with congestive heart failure]. | 2 |
About Weiren Xu
Weiren Xu is a scholar working on Toxicology, Pharmacology and Biochemistry, having authored 98 papers that have together received 1.5k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (15 papers), Diabetes Treatment and Management (11 papers) and Synthesis and biological activity (10 papers). The work is most often cited by research in Toxicology (54 citations), Molecular Biology (902 citations) and Computational Theory and Mathematics (205 citations). Weiren Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Run‐Ling Wang, Shuqing Wang, Tang Li-da, Kuo‐Chen Chou, Fancui Meng, Ying Ma, Xian‐Chao Cheng, Jianwu Wang, Guilong Zhao and Xuyuan Liu. Their work appears in journals such as PLoS ONE, Hepatology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.